ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
ProPhase Labs's pe ratio was 20.8× on Jul 31, 2023, against 8.7× a year earlier. Over the last 3 years it ranged from 0.8× to 91.9×, with a median of 6.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jul 31, 2023 | 20.8× | +16.1 |
| 2022 | Dec 30, 2022 | 4.7× | +3.7 |
| 2018 | Apr 30, 2018 | 1.1× | +0.1 |
| 2017 | Dec 29, 2017 | 0.9× | −65.8 |
| 2014 | Jan 31, 2014 | 66.8× | +14.8 |
| 2013 | Dec 31, 2013 | 51.9× | – |
See a number that looks wrong?